173 related articles for article (PubMed ID: 2551444)
1. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT
Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
Bruijnzeel PL; Warringa RA; Kok PT; Hamelink ML; Kreukniet J
Drugs; 1989; 37 Suppl 1():9-18; discussion 69-77. PubMed ID: 2547570
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
5. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
Bruijnzeel PL; Warringa RA; Kok PT; Hamelink ML; Kreukniet H; Koenderman L
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):159-64. PubMed ID: 8393021
[TBL] [Abstract][Full Text] [Related]
6. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
Carolan EJ; Casale TB
Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
[TBL] [Abstract][Full Text] [Related]
7. Nedocromil sodium inhibits the A23187- and opsonized zymosan-induced leukotriene formation by human eosinophils but not by human neutrophils.
Bruijnzeel PL; Hamelink ML; Kok PT; Kreukniet J
Br J Pharmacol; 1989 Mar; 96(3):631-6. PubMed ID: 2541846
[TBL] [Abstract][Full Text] [Related]
8. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
9. Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects.
e Silva PM; Martins MA; Castro-Faria-Neto HC; Bozza PT; Pires AL; Cordeiro RS; Vargaftig BB
Br J Pharmacol; 1992 Feb; 105(2):436-40. PubMed ID: 1313729
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition by nedocromil sodium of superoxide generation elicited by platelet activating factor in human neutrophils.
Rubin RP; Thompson RH; Naps MS
Agents Actions; 1990 Nov; 31(3-4):237-42. PubMed ID: 1964761
[TBL] [Abstract][Full Text] [Related]
12. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs.
Liu B; Zhang H; Li S; Chen W
Chin Med J (Engl); 1996 Jun; 109(6):467-70. PubMed ID: 9206081
[TBL] [Abstract][Full Text] [Related]
13. Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity.
Rand TH; Lopez AF; Gamble JR; Vadas MA
Int Arch Allergy Appl Immunol; 1988; 87(2):151-8. PubMed ID: 2847986
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium.
Warringa RA; Mengelers HJ; Maikoe T; Bruijnzeel PL; Koenderman L
J Allergy Clin Immunol; 1993 Mar; 91(3):802-9. PubMed ID: 8384226
[TBL] [Abstract][Full Text] [Related]
15. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of receptor-mediated platelet activation by nedocromil sodium.
Roth M; Solèr M; Lefkowitz H; Emmons LR; Anstine D; Hornung M; Perruchoud AP
J Allergy Clin Immunol; 1993 Jun; 91(6):1217-25. PubMed ID: 8389778
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium.
Hayes JP; Chung KF; Barnes PJ
Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735
[TBL] [Abstract][Full Text] [Related]
18. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
e Silva PM; Martins MA; Faria Neto HC; Cordeiro RS; Vargaftig BB
J Pharmacol Exp Ther; 1991 Jun; 257(3):1039-44. PubMed ID: 2046020
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the generation of platelet-activating factor and leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and by the calcium ionophore A23187: the effects of nedocromil sodium.
Burke LA; Crea AE; Wilkinson JR; Arm JP; Spur BW; Lee TH
J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):26-35. PubMed ID: 2153720
[TBL] [Abstract][Full Text] [Related]
20. Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization.
Skedinger MC; Augustine NH; Morris EZ; Nielson DW; Zimmerman GA; Hill HR
J Allergy Clin Immunol; 1987 Oct; 80(4):573-7. PubMed ID: 3117863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
